06-07-2026 09:00 via prnewswire.com

MRX1 Successfully Delivered to Clinical Trial Site

LONDON, July 6, 2026 /PRNewswire/ -- Ananda Pharma Limited is a UK based bio pharmaceutical company developing regulatory approved cannabidiol medicines to treat complex, chronic conditions. The directors announce the MRX1 investigational product manufactured in 2025 has been delivered to...
Read more »